Senior Director
Orna Therapeutics
Cambridge, Massachusetts, United States
Al is the Senior Director, Head of Delivery Sciences at Orna Therapeutics, leading their efforts to bring oRNA to new, therapeutically meaningful tissues and cell types. Al is a classically trained nucleic acid chemist and enzymologist with over ten years in industry focused on nanoparticle development. Al earned his Ph.D. in Chemistry at Boston College, followed by a Post Doc at The Scripps Research Institute, specializing in simplified nucleic acid backbones, their chemical synthesis, and enzymatic processing.
Before joining, Orna Al was an Associate Director and founding member of Moderna’s Delivery Innovation group, focusing on novel materials and processes for effective mRNA delivery across the polymer and lipid nanoparticle spaces. Before Moderna, Al held various scientific and leadership roles at BIND Therapeutics. Al has contributed to multiple clinical and commercial nanoparticle programs at Moderna and BIND therapeutics throughout his career.
Wednesday, July 26, 2023
4:30 PM – 6:30 PM US PST
